The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners-Reference-Cited by-同舟云学术

The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners

Published:2016-03-14 Issue:17 Volume:7 Page:23740-23756
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Yanan¹²,Liu Jie¹,Wang Shibin³,Luo Xiaoli¹,Li Yang³,Lv Zhaohui⁴,Zhu Jie⁴,Lin Jing³,Ding Lihua¹,Ye Qinong¹²

Affiliation:

1. Department of Medical Molecular Biology, Beijing Institute of Biotechnology, Collaborative Innovation Center for Cancer Medicine, Beijing, People's Republic of China

2. Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Liaoning, People's Republic of China

3. First Affiliated Hospital, Chinese PLA General Hospital, Beijing, People's Republic of China

4. Department of Endocrinology, Chinese PLA General Hospital, Chinese PLA Medical School, Beijing, People's Republic of China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DEK-rRNA interactions regulate ribosome biogenesis and stress response;2024-08-23

2. Clinical Potential of YY1-Hypoxia Axis for Vascular Normalization and to Improve Immunotherapy;Cancers;2024-01-23

3. Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions;Cancers;2023-07-05

4. The impact of the chromatin binding DEK protein in hematopoiesis and acute myeloid leukemia;Experimental Hematology;2023-07

5. Role of DEK in carcinogenesis, diagnosis, prognosis, and therapeutic outcome of breast cancer: An evidence-based clinical review;Critical Reviews in Oncology/Hematology;2023-01